Valence Labs (RXRX) — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Valence Labs, founded in 2023 as the AI research arm of Recursion Pharmaceuticals (NASDAQ: RXRX), is a mission-driven unit focused on building foundational AI models for biology. Its core strategy revolves around a three-pillar platform—Predict, Explain, Discover—aimed at creating 'virtual cells' to simulate cellular responses to perturbations. Key achievements include the development of state-of-the-art models like TxPert for out-of-distribution prediction and the generation of a prolific, high-impact research portfolio, positioning it at the forefront of computational biology. By operating as an integrated yet distinct research engine, Valence Labs combines the agility of an academic AI lab with the unique resources of Recursion's automated wet labs and BioHive supercomputer.

AI / Machine Learning

Technology Platform

A three-pillar AI platform (Predict, Explain, Discover) leveraging massive proprietary biological datasets and supercomputing to build foundational models and 'virtual cells' for therapeutic discovery.

Opportunities

Valence Labs is positioned to capitalize on the rapidly growing AI drug discovery market by building foundational 'virtual cell' models that could dramatically reduce the time and cost of therapeutic R&D.

Its unique integration with Recursion's automated labs and massive data generation creates a powerful competitive moat and a direct path to translating research into clinical pipelines.

Risk Factors

Key risks include the high technical uncertainty of achieving accurate whole-cell simulation, dependence on Recursion's financial health for funding, intense competition for AI/biology talent, and the challenge of seamlessly translating AI research into improved clinical-stage outcomes.

Competitive Landscape

Valence competes with integrated AI-biotechs (Exscientia, Insilico), tech-pharma collaborations (Isomorphic Labs, NVIDIA), and academic labs. Its key advantages are proprietary scale of integrated data and wet-lab infrastructure, dedicated supercomputing, and a research culture focused on long-term foundational problems.

More companies in AI / Machine Learning →More companies in United States →